| Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations LL Anderson, MG Etchart, D Bahceci, TA Golembiewski, JC Arnold Scientific reports 11 (1), 14948, 2021 | 48 | 2021 |
| Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the … SM Todd, C Zhou, DJ Clarke, TW Chohan, D Bahceci, JC Arnold European Neuropsychopharmacology 27 (2), 132-145, 2017 | 48 | 2017 |
| Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy LL Anderson, M Heblinski, NL Absalom, NA Hawkins, MT Bowen, ... British journal of pharmacology 178 (24), 4826-4841, 2021 | 47 | 2021 |
| Adolescent behavioral abnormalities in a Scn1a+/− mouse model of Dravet syndrome D Bahceci, LL Anderson, CVOH Brown, C Zhou, JC Arnold Epilepsy & Behavior 103, 106842, 2020 | 31 | 2020 |
| The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a +/− Mouse Model of Dravet Syndrome V Satpute Janve, LL Anderson, D Bahceci, NA Hawkins, JA Kearney, ... Frontiers in Pharmacology 12, 675128, 2021 | 15 | 2021 |
| The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome LL Anderson, PT Doohan, NA Hawkins, D Bahceci, S Garai, GA Thakur, ... Neuropharmacology 205, 108897, 2022 | 12 | 2022 |
| Nrg1 deficiency modulates the behavioural effects of prenatal stress in mice DJ Clarke, L Sarkissian, SM Todd, AS Suraev, D Bahceci, N Brzozowska, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 88, 86-95, 2019 | 9 | 2019 |
| Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression A Rodgers, D Bahceci, CG Davey, ML Chatterton, N Glozier, M Hopwood, ... Australian & New Zealand Journal of Psychiatry 58 (2), 109-116, 2024 | 3 | 2024 |
| Can old drugs learn new tricks? Achieving registration and public subsidy listing for off‐patent medicines with novel therapeutic applications J Brett, D Bahceci, W Lipworth, P Liknaitzky, RO Day, A Rodgers Internal Medicine Journal 53 (7), 1284-1287, 2023 | 3 | 2023 |
| Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet … LL Anderson, DA Bahceci, NA Hawkins, D Everett-Morgan, SD Banister, ... Plos one 18 (1), e0280842, 2023 | 1 | 2023 |
| Hyperthermia-Induced Seizures Enhance Brain Concentrations of the Endocannabinoid-Related Linoleoyl Glycerols in a Scn1a+/− Mouse Model of Dravet … D Bahceci, LL Anderson, RC Kevin, PT Doohan, JC Arnold Cannabis and Cannabinoid Research 8 (3), 495-504, 2023 | | 2023 |
| Preclinical validation of endocannabinoid system drug targets for the treatment of Dravet syndrome D Bahceci University of Sydney, 2020 | | 2020 |
